# Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

> **NCT05440838** · — · RECRUITING · sponsor: **University Hospital, Angers** · enrollment: 120 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **DIAGNOSTIC_TEST:** Next-generation sequencing

## Key facts

- **NCT ID:** NCT05440838
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-17
- **Primary completion:** 2027-02-17
- **Final completion:** 2032-02-17
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05440838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05440838, "Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05440838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*